UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma

Popat, R; Plesner, T; Davies, F; Cook, G; Cook, M; Elliott, P; Jacobson, E; ... Cavenagh, J; + view all (2013) A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , 160 (5) pp. 714-717. 10.1111/bjh.12154.

Full text not available from this repository.
Type: Article
Title: A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma
DOI: 10.1111/bjh.12154
Keywords: Science & Technology, Life Sciences & Biomedicine, Hematology, myeloma, clinical trials, renal medicine, APOPTOSIS, PROTEINS
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: http://discovery.ucl.ac.uk/id/eprint/1380616
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item